Medical Advisory

Dr. Grint was most recently CEO and a member of the board of directors of AmpliPhi Biosciences which recently merged with C3J Therapeutics to form Armata Pharmaceuticals. Dr. Grint has more than two decades of experience in biologics and small molecule research and development, including the successful approval and commercialization of products in the infectious […]

Prof. Andrew Scott is Laboratory Head at the Olivia Newton-John Cancer Research Institute; Director, Department of Molecular Imaging and Therapy, Austin Health; and Professor, University of Melbourne, La Trobe University, and Monash University. His clinical and research interests are focused on developing innovative strategies for targeted therapy of cancer with monoclonal antibodies, and in molecular […]

Dr. Ivkov’s research focuses on the development and characterization of magnetic nanoparticles and AMF-devices for cancer therapy. Upon his arrival to the Department of Radiation Oncology and Molecular Radiation Sciences at The Johns Hopkins University School of Medicine in early 2008, Dr. Ivkov began a broad research program with the aim to develop clinical applications […]

Prof Lisa Horvath is the Director, Department of Medical Oncology, and inaugural Director of Research at the Chris O’Brien Lifehouse. She is also the Professor of Medical Oncology (Genitourinary cancer) at the University of Sydney and Head of Clinical Prostate Cancer Research at the Garvan Institute for Medical Research. She has an active clinical practice […]

John Hazle, Ph.D. is Professor and Chair of the Department of Imaging Physics at one of the world’s largest cancer research and treatment centers. In his role as the Chairman of the Scientific Advisory Board, John represents the interests and professional requirements of an uncompromising customer who buys and uses advanced diagnostic instrumentation on a […]